Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Air pollution may be lowering global IQ and widening inequality, researchers warn

10

Mar 2026

Air pollution may be lowering global IQ and widening inequality, researchers warn

Researchers argue that exposure to fine particulate air pollution (PM2.5) may affect cognitive function and intelligence, potentially causing large population-level losses in global IQ. Using modelling based on published exposure–response data, the authors estimate that pollution could be associated with tens of billions of IQ points lost worldwide, with the largest impacts in lower-income regions.

How social and environmental exposures across life influence mental health risk

10

Mar 2026

How social and environmental exposures across life influence mental health risk

Researchers outline how the exposome framework, which captures the totality of environmental exposures across the lifespan, can help explain how non-genetic factors shape mental health risk and resilience. The perspective highlights how integrating environmental, biological, and social data could improve prevention strategies, research models, and personalized mental health care.

Global study reveals how inequality limits access to exercise and why it matters for health

10

Mar 2026

Global study reveals how inequality limits access to exercise and why it matters for health

A global analysis of physical activity data from 68 countries shows large socioeconomic and gender inequalities in access to choice-based exercise, particularly active leisure. The study also synthesizes evidence linking physical activity to lower risks of severe infectious disease, depression, and cancer mortality, and proposes a new “physical activity for health and wellbeing” public health framework.

Study reveals why US life expectancy gains stalled after decades of progress

10

Mar 2026

Study reveals why US life expectancy gains stalled after decades of progress

A PNAS study analyzing US mortality from 1979 to 2023 reveals that life expectancy stagnation reflects both worsening outcomes in post-1950 birth cohorts and a broad mortality deterioration beginning around 2010. Cardiovascular mortality slowdowns, rising external causes, and cohort-specific patterns help explain the persistent decline in longevity gains.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.